Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Seo Kyoung Chung"'
Autor:
Se Yong Jung, Min Seo Kim, Han Li, Keum Hwa Lee, Ai Koyanagi, Marco Solmi, Andreas Kronbichler, Elena Dragioti, Kalthoum Tizaoui, Sarah Cargnin, Salvatore Terrazzino, Sung Hwi Hong, Ramy Abou Ghayda, Nam Kyun Kim, Seo Kyoung Chung, Louis Jacob, Joe‐Elie Salem, Dong Keon Yon, Seung Won Lee, Karel Kostev, Ah Young Kim, Jo Won Jung, Jae Young Choi, Jin Soo Shin, Soon‐Jung Park, Seong Woo Choi, Kiwon Ban, Sung‐Hwan Moon, Yun Young Go, Jae Il Shin, Lee Smith
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 2, Pp 501-513 (2022)
Abstract On October 2020, the US Food and Drug Administration (FDA) approved remdesivir as the first drug for the treatment of coronavirus disease 2019 (COVID‐19), increasing remdesivir prescriptions worldwide. However, potential cardiovascular (CV
Externí odkaz:
https://doaj.org/article/193ae135de354dc99bb9951ef20e5f30
Autor:
Min Seo Kim, Dawon Seong, Han Li, Seo Kyoung Chung, Youngjoo Park, Minho Lee, Seung Won Lee, Dong Keon Yon, Jae Han Kim, Keum Hwa Lee, Marco Solmi, Elena Dragioti, Ai Koyanagi, Louis Jacob, Andreas Kronbichler, Kalthoum Tizaoui, Sarah Cargnin, Salvatore Terrazzino, Sung Hwi Hong, Ramy Abou Ghayda, Joaquim Radua, Hans Oh, Karel Kostev, Shuji Ogino, I‐Min Lee, Edward Giovannucci, Yvonne Barnett, Laurie Butler, Daragh McDermott, Petre‐Cristian Ilie, Jae Il Shin, Lee Smith
Publikováno v:
REV MED VIROL
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
The aim of this systematic review and network meta-analysis is to evaluate the comparative effectiveness of N95, surgical/medical and non-medical facemasks as personal protective equipment against respiratory virus infection. The study incorporated 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39b03aa6ab7f91556a092ac2373d28e
https://arro.anglia.ac.uk/id/eprint/707338/3/Kim_et_al_2022.pdf
https://arro.anglia.ac.uk/id/eprint/707338/3/Kim_et_al_2022.pdf
Autor:
Kalthoum Tizaoui, Seo Kyoung Chung, Jo Won Jung, Ai Koyanagi, Salvatore Terrazzino, Joe-Elie Salem, Ramy Abou Ghayda, Andreas Kronbichler, Keum Hwa Lee, Jae Young Choi, Louis Jacob, Seung Won Lee, Seong Woo Choi, Marco Solmi, Yun Young Go, Jae Il Shin, Karel Kostev, Jin Soo Shin, Sung-Hwan Moon, Ah Young Kim, Lee Smith, Sung Hwi Hong, Dong Keon Yon, Nam Kyun Kim, Kiwon Ban, Han Li, Min Seo Kim, Elena Dragioti, Sarah Cargnin, Soon-Jung Park, Se Yong Jung
Publikováno v:
Clinical and Translational Science.
Clinical and Translational Science., Wiley, 2021, ⟨10.1111/cts.13168⟩
Clinical and Translational Science, Vol 15, Iss 2, Pp 501-513 (2022)
Clinical and Translational Science., Wiley, 2021, ⟨10.1111/cts.13168⟩
Clinical and Translational Science, Vol 15, Iss 2, Pp 501-513 (2022)
On October 2020, the US Food and Drug Administration (FDA) approved remdesivir as the first drug for the treatment of coronavirus disease 2019 (COVID-19), increasing remdesivir prescriptions worldwide. However, potential cardiovascular (CV) toxicitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e7c008ce84fe77a1d973238aa2fbe2
https://arro.anglia.ac.uk/id/eprint/707069/11/Jung_et_al_2021.pdf
https://arro.anglia.ac.uk/id/eprint/707069/11/Jung_et_al_2021.pdf